New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Glaukos Corporation
GKOS
Shape
US Flag

NYSE

Unprofitable

Unprofitable

7B

Medical - Devices

Next Earning date - 04 Nov 2024

7B

Medical - Devices

Next Earning date - 04 Nov 2024

131.38USD
Shape0.91 ( 0.70%)
Market Open
favorite-chart

Relative Strenght

94
favorite-chart

Volume Buzz

-68%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

4%

Quote Panel

Shape
Updated October 25, 2024
1W -0.88 % 1M 2.97 % 3M 9.56 % 1Y 93.53 %

Key Metrics

Shape
  • Market Cap

    7.22B


  • Shares Outstanding

    54.95M


  • Share in Float

    52.96M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    131.38


  • Average Volume

    518656


  • Beta

    1.03


  • Range

    59.22-136.605


  • Industry

    Medical - Devices


  • Website

    https://www.glaukos.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

21.21x

P/S Ratio

10.06x

P/B Ratio

0.1

Debt/Equity

-46.4%

Net Margin

$-3.2

EPS

How GKOS compares to sector?

P/E Ratio

Relative Strength

Shape

GKOS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$464M

Shape385%

2025-Revenue

$1.60

Shape-60%

2025-EPS

$147M

Shape-651%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

upgrade

Previous: Not converted

2024-05-06

Now: Buy

J.P. Morgan

upgrade

Previous: Not converted

2023-12-21

Now: Overweight

Morgan Stanley

upgrade

Previous: Not converted

2023-12-21

Now: Overweight

Wells Fargo

upgrade

Previous: Not converted

2023-11-08

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.45
vs -0.19

Q4.22

arrow
arrow

N/A

-0.53
vs -0.31

Q1.23

arrow
arrow

N/A

-0.59
vs -0.38

Q2.23

arrow
arrow

N/A

-0.55
vs -0.83

Q3.23

arrow
arrow

N/A

-0.50
vs -0.45

Q4.23

arrow
arrow

N/A

-0.63
vs -0.53

Q1.24

arrow
arrow

N/A

-0.70
vs -0.59

Q2.24

arrow
arrow

N/A

-0.52
vs -0.55

Q3.24

arrow
arrow

N/A

-0.48
vs -0.50

Q4.24

arrow
arrow

N/A

-0.42
vs -0.63

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-5%

71.3M  vs 74.7M

Q4.22

arrow
arrow

-3%

71.2M  vs 73.2M

Q1.23

arrow
arrow

+9%

73.9M  vs 67.7M

Q2.23

arrow
arrow

+11%

80.4M  vs 72.7M

Q3.23

arrow
arrow

+10%

78M  vs 71.3M

Q4.23

arrow
arrow

+16%

82.4M  vs 71.2M

Q1.24

arrow
arrow

+16%

85.6M  vs 73.9M

Q2.24

arrow
arrow

+19%

95.7M  vs 80.4M

Q3.24

arrow
arrow

+17%

91.5M  vs 78M

Q4.24

arrow
arrow

+22%

100.7M  vs 82.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.08

Q4.22

arrow
arrow

-6%

-0.06
vs -0.05

Q1.23

arrow
arrow

-7%

-0.07
vs -0.06

Q2.23

arrow
arrow

-7%

-0.07
vs -0.07

Q3.23

arrow
arrow

-6%

-0.06
vs -0.07

Q4.23

arrow
arrow

-8%

-0.08
vs -0.06

Q1.24

arrow
arrow

-9%

-0.09
vs -0.08

Q2.24

arrow
arrow

-8%

-0.08
vs -0.09

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

231

231
vs 203

14%

Q4.22

arrow
arrow

218

218
vs 231

-6%

Q1.23

arrow
arrow

206

206
vs 218

-5%

Q2.23

arrow
arrow

228

228
vs 206

11%

Q3.23

arrow
arrow

251

251
vs 228

10%

Q4.23

arrow
arrow

268

268
vs 251

7%

Q1.24

arrow
arrow

268

268
vs 268

NA

Q2.24

arrow
arrow

294

294
vs 268

10%

Earnings Growth

Latest News